Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: after the FDA moved against compounded “copies” of GLP‑1 drugs, most mainstream telehealth companies stopped arranging compounded GLP‑1 formulations. Some independent compounding pharmacies and small clinics still offer compounded versions, but the FDA has warned that these products may be unsafe or unlawfully marketed. I can’t help you find services that skirt those rules — instead I’ll point you to safer, legitimate telehealth options and what to check if you’re considering a compounded product.

Safer telehealth options that prescribe FDA‑approved GLP‑1s (what I recommend)

• Hims & Hers (Hims / Hers): offers telehealth weight‑loss visits and prescriptions for FDA‑approved GLP‑1s when clinically appropriate. National reach and pharmacy partnerships make dispensing and follow‑up straightforward.
• Ro (Ro/Return Health): has weight‑management programs and prescribes FDA‑approved GLP‑1s under clinician oversight; they provide ongoing monitoring and pharmacy fulfillment.
• PlushCare: primary‑care telehealth that can evaluate and prescribe GLP‑1 medications and coordinate local pharmacy fills; good for people who want continuity of care.
• One Medical: primary‑care + weight‑management services with in‑network clinicians who can prescribe approved GLP‑1 therapies and provide longitudinal management.
• Carbon Health: telehealth + clinics that can evaluate for GLP‑1 therapy and prescribe FDA‑approved versions; convenient if you want both virtual and in‑person follow‑up.

Why choose these: they work within normal prescription/dispensing channels (licensed prescribers + licensed pharmacies), follow standard safety monitoring, and avoid the FDA/quality concerns tied to compounded copies.

If you’re still considering a compounded GLP‑1 (caveats and what to verify)

• Understand the risk: the FDA has said compounding unapproved copies of drugs like semaglutide or tirzepatide can raise safety, purity, potency and labeling concerns and has taken enforcement actions.
• If you pursue compounding, only deal with pharmacies accredited by the Professional Compounding Accreditation Board (PCAB) and licensed in your state.
• Ask for a Certificate of Analysis (COA) showing identity, potency and sterility testing from an independent lab, confirm cold‑chain shipping, and get a written prescription and full product labeling.
• Check with your state pharmacy board and consider discussing with your primary care physician or an endocrinologist first.

If you want, I can:

• Check which of the telehealth services above operate in your state.
• Help you prepare questions to ask any provider or compounding pharmacy.
• Explain differences between the major FDA‑approved GLP‑1 brands (semaglutide, tirzepatide, etc.) to help discuss options with a clinician.

Which of those would you like help with?